Relationship of femorodistal bypass patency to clinical outcome

European Journal of Vascular and Endovascular Surgery

Volumn 17, Issue 1, 1999, Pages 77-83

  Watson, H R ^a   Schroeder, T V ^b   Simms, M H ^c   Buth, J ^d   Horrocks, M ^e   Norgren, L ^f   Bergqvist, D ^g  

^a BAYER PHARMA AG   (Germany)

^b Rigshospitalet   (Denmark)

^c SELLY OAK HOSPITAL   (United Kingdom)

^d CATHARINA HOSPITAL   (Netherlands)

^e ROYAL UNITED HOSPITAL   (United Kingdom)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amputation; Clinical outcome; Femorodistal bypass; Patency

Indexed keywords

ADULT; AGED; ARTERY BYPASS; ARTERY OCCLUSION; ARTICLE; CLINICAL TRIAL; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; ISCHEMIA; LEG AMPUTATION; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0032996136     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.1998.0712     Document Type: Article

References (15)

1. Underwood CJ, Faragher EB, Charlesworth D. The uses and abuses of life-table methods in vascular surgery. Br J Surg. 71:1984;495-498.
2. Jensen LP, Nielsen OM, Schroeder T.V. The importance of complete follow-up for results after femoroinfrapopliteal vascular surgery. Eur J Vasc Endovasc Surg. 12:1996;282-286.
3. Veith FJ, Gupta SK, Ascer E. Six-year prospective multicentre randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg. 3:1986;104-114.
4. Sørensen S, Lorentzen JE, Schroeder T.V. Prognosis for limb-loss in patients with chronic critical ischemia considered technically inoperable. Vasc Surg. 26:1992;283-289.
5. Iloprost Bypass International Study Group. Effect of perioperative iloprost on patency of femorocrural bypass grafts. Eur J Vasc Endovasc Surg. 12:1996;363-371.
6. Rutherford RB, Baker JD, Ernst C. Recommended standards for reports dealing with lower extremity ischaemia: revised version. J Vasc Surg. 26:1997;517-538.
7. Ray SA, Minty I, Buckenham TM, Belli A-M, Taylor RS, Dormandy J.A. Clinical outcome and restenosis following percutaneous transluminal angioplasty for ischaemic rest pain or ulceration. Br J Surg. 82:1995;1217-1221.
8. Harling H, Lorentzen JE, Nielson OM, Buchardt Hansen H.J. Femorodistal bypass - a worthwhile procedure? Eur J Vasc Surg. 1:1987;133-135.
9. Belch JJF. Evaluating treatment of critical limb ischaemia. Critical Ischaemia. 2:1992;5-12.
10. Troëng T, Bergqvist D, Janson L. Incidence and causes of adverse outcomes of operation for chronic ischaemia of the leg. Eur J Surg. 160:1994;17-25.
11. Wolfe JHN. Defining the outcome of critical ischaemia: a 1-year prospective study. Br J Surg. 73:1986.
12. Dietzek AM, Gupta SK, Kram HB, Wengerter KR, Veith F.J. Limb-loss with patent infrainguinal bypasses. Eur J Vasc Surg. 4:1990;413-417.
13. Raf ferty TD, Avellone JC, Farell C.J. A metropolitan experience with infrainguinal revascularization: operative risks and late results in north-eastern Ohio. J Vasc Surg. 6:1987;365-371.
14. DeWeese JA, Rob C.G. Autogenous venous grafts 10 years later. Surgery. 82:1977;775-784.
15. Beattie DK, Golledge J, Greenhalgh RM, Davies A.H. Quality of life assessment in vascular disease: towards a consensus. Eur J Vasc Endovasc Surg. 13:1997;9-13.